|
Nov 14
|
13 Cheap Blue Chip Stocks To Buy
|
|
Nov 13
|
Robert Bruce's Investment Strategy Leads to Notable Changes in Portfolio, Highlighting Merck ...
|
|
Nov 13
|
10 Healthcare Focused Hedge Funds and 10 Top Stock Picks
|
|
Nov 11
|
Merck & Co., Inc. (NYSE:MRK) is favoured by institutional owners who hold 77% of the company
|
|
Nov 10
|
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Gemcitabine and Cisplatin as First-Line Treatment for Locally Advanced Unresectable or Metastatic Biliary Tract Cancer
|
|
Nov 10
|
7 Biotech Stocks to Buy for Big-Time Gains
|
|
Nov 9
|
Top Analyst Reports for McDonald's, ConocoPhillips & RTX
|
|
Nov 9
|
Deutsche warms to Merck; Ralph Lauren snags a buy rating: 4 big analyst picks
|
|
Nov 8
|
Merck to Participate in the Jefferies London Healthcare Conference
|
|
Nov 6
|
Insiders At Merck Sold US$5.5m In Stock, Alluding To Potential Weakness
|
|
Nov 3
|
The Zacks Analyst Blog Highlights Merck, Bank of America, AMD, Netflix and Union Pacific
|
|
Nov 2
|
Q3 Earnings Season Scorecard and Analyst Reports for Merck, Bank of America & AMD
|
|
Oct 17
|
UPDATE 1-EU regulator backs use of Merck's viral infection drug
|
|
Oct 17
|
Merck Receives Positive EU CHMP Opinion for PREVYMIS® for Prevention of CMV Disease in High-Risk Adult Kidney Transplant Recipients and Extended 200-Day Dosing in Adult HSCT Recipients at Risk for Late CMV Infection and Disease
|
|
Oct 16
|
UPDATE 3-Merck's Keytruda gets FDA nod for expanded use in lung cancer
|
|
Oct 16
|
FDA Approves KEYTRUDA® (pembrolizumab) for Treatment of Patients With Resectable (T≥4 cm or N+) NSCLC in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as a Single Agent as Adjuvant Treatment After Surgery
|
|
Oct 16
|
CHMP Endorses Merck's (MRK) Keytruda Expansion in Gastric Cancer
|
|
Oct 16
|
Is Merck & Co., Inc. (NYSE:MRK) Trading At A 48% Discount?
|
|
Oct 16
|
European Commission Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adults With Non-Small Cell Lung Cancer at High Risk of Recurrence Following Complete Resection and Platinum-Based Chemotherapy
|
|
Oct 15
|
Merck to open £1bn London research centre with plea for government support of industry
|